Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michel Delvaux
Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects With Normal or Impaired Hepatic Function
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
A European Approach to Irritable Bowel Syndrome Management
Canadian Journal of Gastroenterology
Related publications
Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function
Clinical Pharmacology in Drug Development
Pharmacology
Pharmaceutical Science
Synaptic Dysfunction in Human Immunodeficiency Virus Type-1-Positive Subjects: Inflammation or Impaired Neuronal Plasticity?
Journal of Internal Medicine
Internal Medicine
Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects With Normal or Varying Degrees of Impaired Renal Function
Drugs in R and D
Pharmacology
Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Mutation Patterns and Structural Correlates in Human Immunodeficiency Virus Type 1 Protease Following Different Protease Inhibitor Treatments
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Single-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in Patients With Human Immunodeficiency Virus Infection.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Crystal Structure of Human Immunodeficiency Virus (HIV) Type 2 Protease in Complex With a Reduced Amide Inhibitor and Comparison With HIV-1 Protease Structures.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary